April 25, 2020
– Devonian Health ups its non-brokered financing to $2M
Devonian Health Group has increased its non-brokered financing to $2M.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Devonian Health Group
April 22, 2020
Dev. Health issues interest settlement securities
QUÉBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on…
April 8, 2019
Devonian Health Group Announces the Publication of Results of in Vitro Assessment of the Antioxidant and UV Protection Properties of Thylakoid Extracts in Journal of Cosmetic Dermatology.
QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on developing…
April 1, 2019
Devonian Health Group Issues Securities in Interest Settlement Due to Debenture Holders and Grants Options
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc.…